Company profile: ReachBio
1.1 - Company Overview
Company description
- Provider of biology-based research services and products to the drug development and life science research communities.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ReachBio
H2 Pharma
HQ: France
Website
- Description: Provider of non-sterile liquid pharmaceutical specialties, producing mouthwash, syrup, and oral solutions while controlling the entire drug value chain from sourcing active ingredients to production. Offers pharmaceutical development under strict GMP with advanced equipment, fully automated dedicated production lines to prevent cross-contamination, and pharmacovigilance and medical information services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full H2 Pharma company profile →
Denison Pharmaceuticals
HQ: United States
Website
- Description: Provider of turn-key formulation, manufacturing, packaging, and testing solutions for branded OTC, Rx, and cosmetic markets. Services include technical operations from concept to commercialization; commercial manufacturing in nine compounding suites up to 2,000 gallons; packaging on 16 high-speed lines for liquids, tubes, jars, and aerosols; cGMP analytical, microbiological, and stability labs; validation and USP Monograph testing; and formulation and reverse-engineering.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Denison Pharmaceuticals company profile →
Asymchem
HQ: China
Website
- Description: Provider of CDMO and pharmaceutical manufacturing services and biotech solutions, focused on R&D of pharmaceutical raw materials synthesis technology applied to drug development and production, supporting efficient, flexible processes and accelerating the commercial launch of biotech products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Asymchem company profile →
BioInformatics
HQ: United States
Website
- Description: Provider of market research and analysis for the analytical instrumentation and life science industries. Services span market sizing and forecasts, vendor share and regional breakouts, product configuration and pricing optimization, acquisition validation, brand loyalty and strength measurement, scientific market assessments, and the bi-monthly Instrument Business Outlook Newsletter.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioInformatics company profile →
Upperton Pharma Solutions
HQ: United Kingdom
Website
- Description: Provider of pharmaceutical contract development and manufacturing services for biotech and pharma, offering formulation development (powders, capsules, tablets) from feasibility to clinical manufacture; Phase 1–3 clinical supply; process scale-up and optimisation; registration activities; analytical development and validation; and UpperNose, a nasal product development platform for small and mid-sized innovators.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Upperton Pharma Solutions company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ReachBio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ReachBio
2.2 - Growth funds investing in similar companies to ReachBio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ReachBio
4.2 - Public trading comparable groups for ReachBio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →